EX-10.38C 7 ex10_38c.htm SECOND AMENDMENT FO SELECTIVE WAIVER AGREEMENTSelective Waiver Agreement • May 5th, 2020
SELECTIVE WAIVER AGREEMENT BY AND BETWEEN ALPHARMA, INC. , AND TEVA PHARMACEUTICAL INDUSTRIES LTD. DATED APRIL 26, 2004Selective Waiver Agreement • January 12th, 2005 • Alpharma Inc • Pharmaceutical preparations • New York
ContractSelective Waiver Agreement • November 5th, 2004 • Alpharma Inc • Pharmaceutical preparations
THIS AMENDMENT NUMBER ONE (the "Amendment") to the Original Agreements (as defined below) is hereby made as of September 24, 2004 by and between Alpharma, Inc., a Delaware corporation ("ALO"), and Purepac Pharmaceutical Co., a Delaware corporation ("Purepac"), on the one hand, and Teva Pharmaceutical Industries Ltd., an Israeli corporation ("Teva"), and Plantex USA, Inc. , a New Jersey corporation ("Plantex"), on the other hand. ALO, Purepac, Teva and Plantex are sometimes collectively referred to herein as the "Parties" and separately as a "Party";
October 7, 2004 Teva Pharmaceutical Industries Ltd. Plantex USA, Inc. Gentlemen: This is to confirm that the date of ******** shall, and hereby is, inserted in lieu of the date of ********" in Section 2 c. of the September 24, 2004 Amendment Number...Selective Waiver Agreement • November 5th, 2004 • Alpharma Inc • Pharmaceutical preparations
This letter shall be effective as of the date hereof and, except as set forth herein, the Selective Waiver Agreement, Amended and Restated Supply Agreement and Amendment Number One thereto shall remain in full force and effect and shall be other wise unaffected. This letter may be executed in any number of counterparts, each of such counterparts shall for all purposes be deemed an original, but all such counterparts shall together constitute but one and the same instrument.
ContractSelective Waiver Agreement • January 12th, 2005 • Alpharma Inc • Pharmaceutical preparations
THIS AMENDMENT NUMBER ONE (the "Amendment") to the Original Agreements (as defined below) is hereby made as of September 24, 2004 by and between Alpharma, Inc., a Delaware corporation ("ALO"), and Purepac Pharmaceutical Co., a Delaware corporation ("Purepac"), on the one hand, and Teva Pharmaceutical Industries Ltd., an Israeli corporation ("Teva"), and Plantex USA, Inc. , a New Jersey corporation ("Plantex"), on the other hand. ALO, Purepac, Teva and Plantex are sometimes collectively referred to herein as the "Parties" and separately as a "Party";
